menu
    • menu

    Company profile for Insulet Corporation

    NEW Drugs in Dev: 1
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, wit...
    Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod® Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Insulet CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 Nagog Park Acton, MA 01720
    Telephone
    Telephone
    (+1) 978-600-7000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.insulet.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Insulet to Report Q4 FY 2025 Results on Feb. 18, 2026
    Insulet to Report Q4 FY 2025 Results on Feb. 18, 2026

    09 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260109369927/en/Insulet-to-Announce-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-February-18-2026

    BUSINESSWIRE
    09 Jan 2026
    Share Share
    Insulet Redefines Diabetes With
    Insulet Redefines Diabetes With "Liveable Technology" At CES

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106462689/en/Insulet-Redefines-Diabetes-at-CES-with-Liveable-Technology-A-New-Frontier-in-Human-Centered-Connected-Health

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Insulet To Present At 44Th J.P. Morgan Healthcare Conference
    Insulet To Present At 44Th J.P. Morgan Healthcare Conference

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216562336/en/Insulet-to-Participate-in-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    Insulet Unveils FDA Clearance For Omnipod® 5 Algorithm
    Insulet Unveils FDA Clearance For Omnipod® 5 Algorithm

    04 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251204178236/en/Insulet-Announces-FDA-510k-Clearance-of-Omnipod-5-Algorithm-Enhancements-that-Redefine-Insulin-Delivery-and-Simplify-the-Pod-Experience

    BUSINESSWIRE
    04 Dec 2025
    Share Share
    Insulet Reveals Growth Strategy At 2025 Investor Conference
    Insulet Reveals Growth Strategy At 2025 Investor Conference

    20 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251120914903/en/Insulet-Outlines-Long-Term-Strategy-to-Drive-Growth-and-Value-Creation-at-2025-Investor-Day

    BUSINESSWIRE
    20 Nov 2025
    Share Share
    Insulet Reports Third Quarter 2025 Results
    Insulet Reports Third Quarter 2025 Results

    06 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251106377212/en/Insulet-Reports-Third-Quarter-2025-Results

    BUSINESSWIRE
    06 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search